Stock XERS XERIS BIOPHARMA HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Xeris Biopharma Holdings, Inc.

Equities

XERS

US98422E1038

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
1.75 USD +2.94% Intraday chart for Xeris Biopharma Holdings, Inc. +0.57% -25.53%
Mar. 28 Oppenheimer Initiates Coverage on Xeris Biopharma With Outperform Rating, $5 Price Target MT
Mar. 18 Xeris Biopharma Holdings, Inc.(NasdaqGS:XERS) added to S&P Pharmaceuticals Select Industry Index CI

Evolution of the average Target Price on Xeris Biopharma Holdings, Inc.

Price target over the last 5 years

History of analyst recommendation changes

e13688bd5a7bac0dfc27a.tD6MCEwdjruMtQIpRhLabgg0k3kgBX1iox-yrUzHzMo.zWfeWTtJ9I3L8VhTEkOPJU8Z4jgVXSdP2W_BwhnzmZj1RuYlfiTb4_b-dQ~1b97262e6e544670057131d0944f31e7

Analyst Recommendations on Xeris Biopharma Holdings, Inc.

Oppenheimer Initiates Coverage on Xeris Biopharma With Outperform Rating, $5 Price Target MT
Craig-Hallum Initiates Xeris Biopharma Holdings at Buy Rating With $4.50 Price Target MT
SVB Securities Trims Xeris Biopharma Price Target to $5 From $6, Maintains Outperform Rating MT
Jefferies Starts Xeris Biopharma Holdings at Buy With $4 Price Target MT
Craig-Hallum Starts Xeris Biopharma Holdings at Buy With $6.50 Price Target MT
Mizuho Securities Adjusts Xeris Biopharma Holdings' Price Target to $6 From $8, Keeps Buy Rating MT
SVB Leerink Adjusts Xeris Biopharma Holdings Price Target to $6 From $8, Maintains Outperform Rating MT
SVB Leerink Raises Price Target on Xeris Biopharma Holdings to $8 From $6, Maintains Outperform Rating MT
HC Wainwright Raises Price Target on Xeris Biopharma Holdings to $5.40 From $4.25, Maintains Buy Rating MT
SVB Leerink Starts Xeris Pharmaceuticals at Outperform With $6 Price Target MT
HC Wainwright Starts Xeris Pharmaceuticals at Buy With $4 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
1.75 USD
Average target price
4.75 USD
Spread / Average Target
+171.43%
High Price Target
6 USD
Spread / Highest target
+242.86%
Low Price Target
4 USD
Spread / Lowest Target
+128.57%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Xeris Biopharma Holdings, Inc.

Oppenheimer
Craig-Hallum
SVB Securities LLC
Jefferies & Co.
Mizuho Securities
SVB Leerink
HC Wainwright

Ratings for Xeris Biopharma Holdings, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. XERS Stock
  4. Consensus Xeris Biopharma Holdings, Inc.